Posterior reversible encephalopathy syndrome associated with Guillain‐Barré syndrome: Case report and clinical management considerations. Issue 3 (14th April 2020)

• Record Type: Journal Article
• Authors: Salvalaggio, Alessandro; Cagnin, Annachiara; Marson, Piero; Ferracci, Franco; Cortelli, Pietro; Corbetta, Maurizio; Briani, Chiara
• Is Part Of: Journal of clinical apheresis. Volume 35:Issue 3(2020)
• Page Start: 231
• Page End: 233
• Publication Date: 2020-04-14
• Subjects: dysautonomia -- Guillain‐Barré syndrome -- intravenous immunoglobulins -- plasma exchange -- posterior reversible encephalopathy syndrome; Hemapheresis -- Periodicals; Blood -- Transfusion -- Periodicals; Blood -- Transfusion, Autologous -- Periodicals; Cell separation -- Periodicals; Leukapheresis -- Periodicals; Plasmapheresis -- Periodicals; 615.39
• DOI: 10.1002/jca.21783
• Languages: English
• ISSNs: 0733-2459

Abstract

Abstract: Around half of the patients with Guillain‐Barré syndrome (GBS) present autonomic dysfunction requiring admission to intensive care unit in up to a quarter of patients. Treatment of GBS consists of plasma exchange (PE) and intravenous immunoglobulins (IVIG). Posterior reversible encephalopathy syndrome (PRES) consists in a reversible subcortical vasogenic brain edema caused by endothelial damage triggered by abrupt blood pressure changes. We report on a woman who presented with PRES in the course of GBS treated first with IVIG, and then with PE. The present report underlines the challenge that the clinicians face when these two rare syndromes concur. The literature is not helpful considering that both blood pressure fluctuations and IVIG are reported to be involved in the pathogenesis of PRES. In the present letter, both pathogenic mechanisms and clinical management considerations are discussed.